Page 217 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

Disorders of Phosphorus: Hypophosphatemia and Hyperphosphatemia 207

children with azotemia not undergoing dialysis. N Engl J 27. Busse JC, Gelbard MA, Byrnes JJ, et al. Pseudohyperphos-
Med 1984;310:1079–84. phatemia and dysproteinemia. Arch Intern Med
7. Andreoli SP, Dunson J, Bergstein JM. Calcium carbonate 1987;147:2045–6.
is an effective phosphorus binder in children with chronic 28. Calia CM, Hohenhaus AE, Fox PR, et al. Acute tumor
renal failure. Am J Kidney Dis 1987;9:206–10. lysis syndrome in a cat with lymphoma. J Vet Intern
8. Aroch I, Srebro H, Shpigel NY. Serum electrolyte Med 1996;10:409–11.
concentrations in bitches with eclampsia. Vet Rec 29. Carillo JM, Burk RL, Bode C. Primary hyperparathyroid-
1999;145:318–20. ism in a dog. J Am Vet Med Assoc 1979;174:67–71.
9. Atkins CE, Tyler R, Greenlee P. Clinical, biochemical, 30. Carlson GP. Fluid, electrolyte, and acid base balance.
acid-base, and electrolyte abnormalities in cats after hyper- In: Kaneko JJ, editor. Clinical biochemistry of domestic
tonic sodium phosphate enema administration. Am J Vet animals. 4th ed. New York: Academic Press; 1989.
Res 1985;46:980–8. p. 543–575.
10. Austad R, Bjerkas E. Eclampsia in the bitch. J Small Anim 31. Chew DJ, Meuten DJ. Disorders of calcium and phospho-
Pract 1976;17:795–8. rus metabolism. Vet Clin North Am 1982;12:411–38.
11. Barber PJ, Rawlings JM, Markwell PJ, et al. Effect of die- 32. Clark CL, Sacks GS, Dickerson RN, et al. Treatment of
tary restriction on renal secondary hyperparathyroidism hypophosphatemia in patients receiving specialized nutri-
in the cat. J Small Anim Pract 1999;40:62–70. tion support using a graduated dosing scheme. Results
12. Bellinghieri G, Santoro D, Savica V. Emerging drugs from a prospective clinical trial. Crit Care Med
for hyperphosphatemia. Expert Opin Emerg Drugs 1995;23:1504–11.
2007;12:355–65. 33. Clarkson EM, McDonald SJ, deWardener HE. The effect
13. Berger B, Feldman EC. Primary hyperparathyroidism of a high intake of calcium carbonate in normal subjects
in dogs: 21 cases (1976–1986). J Am Vet Med Assoc and patients with chronic renal failure. Clin Sci
1987;191:350–6. 1966;30:425–38.
14. Berlyne GM, Ben-Ari J, Pest D, et al. Hyperaluminaemia 34. Clarkson EM, Luck VA, Hynson WV, et al. The effect of
from aluminum resins in renal failure. Lancet aluminum hydroxide on calcium, phosphorus, and alumi-
1970;2:494–6. num balances, the serum parathyroid hormone concentra-
15. Betro MG, Pain RW. Hypophosphatemia and hyperpho- tion and the aluminum content of bone in patients with
sphatemia in a hospital population. Lancet 1972;1:273–6. chronic renal failure. Clin Sci 1972;43:519–31.
16. Bleyer AJ, Burke SK, Dillon M, et al. A comparison of the 35. Coburn JW, Salusky IB. Control of serum phosphorus in
calcium-free phosphate binder sevelamer hydrochloride uremia. N Engl J Med 1989;320:1140–2.
with calcium acetate in the treatment of hyperphos- 36. Coladonato J. Control of hyperphosphatemia among
phatemia in hemodialysis patients. Am J Kidney Dis patients with ESRD. J Am Soc Nephrol 2005;16:
1999;33:694–701. S107–S114.
17. Bloom F. The blood chemistry of the dog and cat. 37. Cozzolino M, Staniforth ME, Liapis H, et al. Sevelamer
New York: Gamma Publications; 1960. hydrochloride attenuates kidney and cardiovascular
18. Bovee KC, Joyce T, Blazer-Yost B, et al. Characterization calcifications in long-term experimental uremia. Kidney
of renal defects in dogs with a syndrome similar to Int 2003;64:1653–61.
Fanconi syndrome in man. J Am Vet Med Assoc 38. Craddock PR, Yawata Y, VanSanten L, et al. Acquired
1979;174:1094–9. phagocyte dysfunction. N Engl J Med 1974;290:1403–7.
19. Brautbar N, Leibovici H, Massry SG. On the mechanism 39. Crenshaw KL, Peterson ME. Pretreatment of clinical and
of hypophosphatemia during acute hyperventilation: evi- laboratoryevaluationofcatswithdiabetesmellitus:104cases
dence for increased muscle glycolysis. Miner Electrolyte (1992–1994). J Am Vet Med Assoc 1996;209:943–9.
Metab 1983;9:45–50. 40. Cushner HM, Copley JB, Lindberg JS, et al. Calcium cit-
20. Breitschwerdt EB, Halliwell WH, Foley CW, et al. A rate, a non-aluminum-containing phosphate-binding
hereditary diarrhetic syndrome in the basenji agent for treatment of CRF. Kidney Int 1988;33:95–9.
characterized by malabsorption, protein losing entero- 41. Datta H, Malik M, Neely R. Hepatic surgery-related
pathy, and hypergammaglobulinemia. J Am Anim Hosp hypophosphatemia. Clin Chim Acta 2007;380:13–23.
Assoc 1980;16:551–60. 42. Delmez JA, Kelber J, Norword KY, et al. Magnesium car-
21. Brown AJ, Dusso A, Lopez-Hilker S, et al. 1,25-(OH) 2 D bonate as a phosphorus binder: a prospective controlled
receptors are decreased in parathyroid glands from chron- crossover study. Kidney Int 1996;49:163–7.
ically uremic dogs. Kidney Int 1989;35:19–23. 43. den Hertog E, Goossens MM, van der Linde Sipman JS,
22. Brown S, Finco D, Crowell WA, et al. Beneficial effect of et al. Primary hyperparathyroidism in two cats. Vet Q
moderate phosphate restriction in partially nephrectomized 1997;19:81–4.
dogs on a low protein diet (abstract). Kidney Int 44. DeVries SE, Feldman EC, Nelson RW, et al. Primary para-
1987;31:380. thyroid gland hyperplasia in dogs: six cases (1982–1991).
23. Bruskiewicz KA, Nelson RW, Feldman EC, et al. Diabetic J Am Vet Med Assoc 1993;202:1132–6.
ketosis and ketoacidosis in cats: 42 cases (1980–1995). 45. D’Haese PC, Spasovski GB, Sikole A, et al. A multicenter
J Am Vet Med Assoc 1997;211:188–92. study on the effects of lanthanum carbonate (Fosrenol)
24. Bruyette DS, Feldman EC. Primary hypoparathyroidism and calcium carbonate on renal bone disease in dialysis
in the dog. J Vet Intern Med 1988;2:7–14. patients. Kidney Int 2003;63:S73–S78.
25. Burk RL, Schaubhut CW. Spontaneous primary 46. DiBartola SP, Chew DJ, Jacobs G. Quantitative urinalysis
hypoparathyroidism in a dog. J Am Anim Hosp Assoc including 24-hour urinary protein excretion in the dog.
1975;11:784–5. J Am Anim Hosp Assoc 1980;16:537–46.
26. Burrows CF, Bovee KC. Metabolic changes due to exper- 47. DiPalma JA, Buckley SE, Warner BA, et al. Biochemical
imentally-induced rupture of the canine urinary bladder. effects of oral sodium phosphate. Dig Dis Sci
Am J Vet Res 1974;35:1083–8. 1996;41:749–53.